These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2419019)

  • 1. A double-blind clinical trial of the effects of inosine pranobex in immunodepressed patients with prolonged generalized lymphadenopathy.
    Wallace JI; Bekesi JG
    Clin Immunol Immunopathol; 1986 Apr; 39(1):179-86. PubMed ID: 2419019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS.
    Bekesi JG; Tsang PH; Wallace JI; Roboz JP
    J Clin Lab Immunol; 1987 Dec; 24(4):155-61. PubMed ID: 2452254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.
    Glasky AJ; Gordon JF
    Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.
    De Simone C; Albertini F; Almaviva M; Angarano G; Chiodo F; Costigliola P; Delia S; Ferlini A; Gritti F; Mazzarello G
    Med Oncol Tumor Pharmacother; 1989; 6(1):63-7. PubMed ID: 2471025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study.
    Davidson-Parker J; Dinsmore W; Khan MH; Hicks DA; Morris CA; Morris DF
    Genitourin Med; 1988 Dec; 64(6):383-6. PubMed ID: 2465265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosiplex treatment of acquired immunodeficiencies: a clinical model for effective immunomodulation.
    Glasky AJ; Gordon J
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):35-40. PubMed ID: 2422507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of zidovudine and concomitant inosine-pranobex in AIDS patients.
    De Simone C; Ferrazzi M; Bitonti F; Falciano M; Tzantzoglou S; Delia S; Sorice F
    Immunopharmacol Immunotoxicol; 1988; 10(4):437-41. PubMed ID: 2469710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
    Brzeski M; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1990 May; 49(5):293-5. PubMed ID: 1693065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosine pranobex in the treatment of HIV infection: a review.
    De Simone C; Famularo G; Tzantzoglou S; Moretti S; Jirillo E
    Int J Immunopharmacol; 1991; 13 Suppl 1():19-27. PubMed ID: 1726683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
    Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
    N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism and modulation of immune dysfunction in AIDS associated syndromes.
    Bekesi JG; Tsang P; Roboz JP
    Adv Exp Med Biol; 1985; 187():141-50. PubMed ID: 2412416
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive effects of isoprinosine in man: a comparison to chlorambucil effects in multiple sclerosis.
    Pompidou A; Rancurel G; Delsaux MC; Meunier C; Telvi L; Cour V; Buge A
    Cancer Detect Prev Suppl; 1987; 1():377-83. PubMed ID: 2446758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imunovir in the treatment of immunodepression of diverse etiology.
    O'Neill BB; Glasky AJ
    Cancer Detect Prev Suppl; 1987; 1():329-31. PubMed ID: 2446757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of first-attack genital herpes--acyclovir versus inosine pranobex.
    Mindel A; Kinghorn G; Allason-Jones E; Woolley P; Barton I; Faherty A; Jeavons M; Williams P; Patou G
    Lancet; 1987 May; 1(8543):1171-3. PubMed ID: 2437417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.
    Mindel A; Carney O; Sonnex C; Freris M; Patou G; Williams P
    Genitourin Med; 1989 Apr; 65(2):103-5. PubMed ID: 2473952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of inosine pranobex and acyclovir.
    Mindel A
    Am J Med; 1988 Aug; 85(2A):7-9. PubMed ID: 2457315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind clinical trial of isoprinosine and placebo in herpetic keratitis].
    Haut J; Debrat G; Moulin F; Monin C; Sarnikovski C
    Bull Soc Ophtalmol Fr; 1983 May; 83(5):617-20. PubMed ID: 6200245
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunostimulation in the lymphadenopathy syndrome and in AIDS--Inosiplex (inosin pranobex, methisoprinol].
    Grossmann D; Behrens MI
    Onkologie; 1987 Jun; 10(3 Suppl):12-6. PubMed ID: 2443884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.
    Beran J; Šalapová E; Špajdel M;
    BMC Infect Dis; 2016 Nov; 16(1):648. PubMed ID: 27821093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.